Please login to the form below

Not currently logged in


This page shows the latest value news and features for those working in and with pharma, biotech and healthcare.

Novo Nordisk growth takes a hit with China deal

Novo Nordisk growth takes a hit with China deal

Danish diabetes specialist Novo Nordisk cuts its growth forecast for 2022 following a value-based procurement deal with the Chinese government for its insulin products. ... The value-based procurement (VBP) process in China will cover all insulins

Latest news

More from news
Approximately 38 fully matching, plus 2,450 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 21 fully matching, plus 736 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 218 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 20 fully matching, plus 722 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Oxford PharmaGenesis

Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups....

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...